InvestorsHub Logo
Followers 148
Posts 9079
Boards Moderated 0
Alias Born 05/17/2005

Re: Brenum post# 46263

Monday, 11/18/2013 1:13:05 PM

Monday, November 18, 2013 1:13:05 PM

Post# of 403316
These two latest drugs are related somewhat to Brilacidin and the antibiotic / antifungal areas of medicine and as such they would also have extremely short trials. We also don't know just how far along they currently are since they came in the Poly deal and so they may be just about ready for trials. Not all trials are like Kevetrin and take years per phase.

Leo is in a hard place since on one hand people condemn one trick pony stocks and then he gets a number of promising drugs and gets slapped for trying to keep too many plates in the air.

I will leave it to Dr M to determine how many projects can be efficiently handled by current staff. He seems happy so I won't find fault with current proceedings.

Have to remember that EACH of our products are in markets of $B+.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News